Günter Schabert

This inventor holds 10 USPTO granted patents and 2 published patent applications and 3 EPO patents. Top assignees: Biosynth Ag, Roche Diagnostics Operations, Inc.. Active years: 2000-2025.

USPTO Granted Patents = 10 (Patent Applications = 2)

% Patents Active = 100.0

EPO Patents = 3 (Patent Applications = 10)

Average Co-Inventor Count = 3.8

ph-index = 2

Forward Citations = 11(Granted Patents)

Company Filing History:

Roche Diagnostics Operations, Inc.

patents

Years Active: 2000-2025

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12358940 - Method of making nicotinamide ribofuranoside salts, nicotinamide ribofuranoside salts as such, and uses thereof (2025-07-15),

2. 12344629 - Method of making nicotinamide ribofuranoside salts, nicotinamide ribofuranoside salts as such, and uses thereof (2025-07-01),

3. 12180244 - (Thio)nicotinamide ribofuranoside salts and compositions, methods of making, and uses thereof (2024-12-31),

4. 11584771 - Method of making nicotinamide ribofuranoside salts, nicotinamide ribofuranoside salts as such, and uses thereof (2023-02-21),

5. 11447514 - (Thio)nicotinamide ribofuranoside salts and compositions, methods of making, and uses thereof (2022-09-20),

6. 9157917 - Applications of Indoloindole and Indoloquinoline dyes (2015-10-13),

7. 9127303 - Method for detection of beta-D-glucuronidase activity in a sample (2015-09-08),

8. 8940909 - Indicator platform (2015-01-27),

9. 6068988 - Detection of microbial metabolites with a (2000-05-30),

10. 6051391 - Detection of microbial metabolites (2000-04-18),

Title: Günter Schabert: Innovator in Nicotinamide Ribofuranoside Salts

Introduction

Günter Schabert is a notable inventor based in Goldach, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of nicotinamide ribofuranoside salts. With a total of 10 patents to his name, Schabert's work has implications for both nutritional supplements and pharmaceutical compositions.

Latest Patents

One of Schabert's latest patents is focused on a method of making nicotinamide ribofuranoside salts. This invention details the process of creating pharmaceutically acceptable nicotinamide ribofuranoside salts, specifically carboxylic acid salts in crystalline form. The patent also discusses the various uses of these salts in nutritional supplements and pharmaceutical applications.

Career Highlights

Throughout his career, Schabert has worked with prominent companies in the pharmaceutical industry. Notable among these are Biosynth AG and Roche Diagnostics Operations, Inc. His experience in these organizations has contributed to his expertise and innovative capabilities in the field.

Collaborations

Schabert has collaborated with several professionals in his field, including Urs P. Spitz and Aysel Soydemir. These collaborations have likely enriched his work and expanded the impact of his inventions.

Conclusion

Günter Schabert's contributions to the development of nicotinamide ribofuranoside salts highlight his innovative spirit and dedication to advancing pharmaceutical science. His patents and collaborations reflect a commitment to improving health through scientific innovation.